January 2019
Volume 14 Issue 1 |
|
|
|
|
advertisement
 |
|
Features
Fluorescence has long been used to detect biological targets. As these measurements are becoming more and more quantitative, standards are needed to ensure accuracy and reproducibility.
/ read more /
|
|
|
Subscribe
Subscribers can enjoy each full issue of Pharmaceutical Technology in print or via the PharmTech app.
subscription offers |
 |
|
|
|
Unprocessed bulk material harvested directly from the bioreactor should be tested for contamination prior to downstream processing.
/ read more /
|
|
|
News
New FDA guidance developed to identify lapses in data integrity and promote best practices.
/ read more /
The companies entered a license agreement for the Trianni Mouse, a transgenic mouse R&D platform for the discovery of fully-human monoclonal antibodies (mAbs), to support MacroGenics’ discovery programs for mAb-based therapeutics.
/ read more /
The merged company will provide histopathology services in the research and pre-clinical therapeutics markets.
/ read more /
Eli Lilly and AC Immune have signed a license and collaboration agreement focussing on the R&D of tau aggregation inhibitor small molecules for the potential treatment of neurodegenerative diseases.
/ read more /
|
|
|
New Technology
The Steritest NEO device from MilliporeSigma provides safer pharmaceutical product testing through additional features.
/ read more /
TrendMiner 2018.R2 software for analysis of time-series data includes the ContextHub platform for expanded, self-service analytics capabilities.
/ read more /
A new plasma B-cell antibody discovery workflow launched by Berkeley Lights enables the shortening of antibody drug discovery from months to a day.
/ read more /
The new reagents are designed to support clinical-phase and commercialization stages of cell and gene therapy production and to enhance DNA transfection.
/ read more /
|
|
|
|
|
